Guardant Health (GH) Income from Non-Controlling Interests (2018 - 2021)
Guardant Health (GH) posted Income from Non-Controlling Interests of $18.6 million for Q4 2021, up 708.7% sequentially from $2.3 million in Q1 2021, and up 2557.14% YoY from $700000.0 in Q4 2020.
Guardant Health (GH) Income from Non-Controlling Interests (2018 - 2021) Analysis & Trends
Guardant Health has reported Income from Non-Controlling Interests for 4 years, with the latest figure at $18.6 million in Q4 2021.
- Quarterly Income from Non-Controlling Interests rose 2557.14% year-over-year to $18.6 million in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $18.6 million (up 520.0% YoY) and the FY2021 annual result came in at $20.9 million, up 178.67% from the prior year.
- Income from Non-Controlling Interests grew to $18.6 million in Q4 2021 per GH's latest filing, from $2.3 million in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $18.6 million in Q4 2021 and troughed at -$4.1 million in Q1 2020.
- A 4-year average of $3.1 million and a median of $1.6 million in 2018 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2020 and 2021: Income from Non-Controlling Interests slumped 187.23% in 2020, then jumped 2557.14% in 2021.
- Over 4 years, Income from Non-Controlling Interests stood at -$150000.0 in 2018, then surged by 2166.67% to $3.1 million in 2019, then plunged by 77.42% to $700000.0 in 2020, then surged by 2557.14% to $18.6 million in 2021.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $18.6 million, $2.3 million, and $700000.0 for Q4 2021, Q1 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.78 Bn | 209.71 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 139.83 Bn | 135.48 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 45.99 Bn | 45.79 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.31 Bn | 37.23 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Natera | 38.74 Bn | 37.64 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.94 Bn | 28.77 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.55 Bn | 28.50 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 14.00 Mn |
| 10 | Guardant Health | 21.60 Bn | 20.54 Bn | 219.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 18.60 Mn |
| Mar 31, 2021 | 2.30 Mn |
| Dec 31, 2020 | 700,000.00 |
| Sep 30, 2020 | 6.00 Mn |
| Jun 30, 2020 | 4.90 Mn |
| Mar 31, 2020 | -4.10 Mn |
| Dec 31, 2019 | 3.10 Mn |
| Sep 30, 2019 | -300,000.00 |
| Jun 30, 2019 | 300,000.00 |
| Mar 31, 2019 | 4.70 Mn |
| Dec 31, 2018 | -150,000.00 |
| Sep 30, 2018 | 950,000.00 |